Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Sammanfattning

Conclusions: Our data support the notion that early inflammatory control in MS is essential to preserve a healthy state in MS that counteracts the negative consequences of the disease both at a personal and at a societal level.

Nyckelord

Multiple sclerosis; work ability; biological drugs; natalizumab

Publicerad i

Multiple Sclerosis
2013, volym: 19, nummer: 5, sidor: 622-630
Utgivare: SAGE PUBLICATIONS LTD

SLU författare

• Nyström, Josefina

  • Institutionen för skogens biomaterial och teknologi, Sveriges lantbruksuniversitet
    

Globala målen (SDG)

SDG8 Anständiga arbetsvillkor och ekonomisk tillväxt

UKÄ forskningsämne

Neurovetenskaper
Neurologi

Publikationens identifierare

• DOI: https://doi.org/10.1177/1352458512461391

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/53989